SCHEMBL8377363

SCHEMBL8377363

COc1ccc(C(NC(=O)OCC2c3ccccc3-c3ccccc32)c2cc(CCC(=O)O)ccc2OC)cc1

nearest known ligand 0.43

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ MDM2 Q00987 1/20 0.43
▸ KMT2A Q03164 5/20 0.43
▸ CASP3 P42574 2/20 0.42
▸ PTPN1 P18031 4/20 0.41
▸ FFAR1 O14842 2/20 0.41
▸ FFAR4 Q5NUL3 1/20 0.39
▸ FABP5 Q01469 1/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7867949 0.88 MDM2 (0.43) MDM2KMT2ACASP3PTPN1FABP5
SCHEMBL12555211 0.82 KMT2A (0.47) MDM2KMT2ACASP3FABP5MEN1
SCHEMBL6343752 0.82 KMT2A (0.45) MDM2KMT2ACASP3PTPN1FABP5
SCHEMBL19228294 0.82 KMT2A (0.41) MDM2KMT2ACASP3PTPN1FABP5
SCHEMBL9730060 0.81 MDM2 (0.47) MDM2KMT2ACASP3FABP5MEN1
SCHEMBL7772788 0.80 KMT2A (0.46) MDM2KMT2ACASP3PTPN1FFAR1
SCHEMBL13523948 0.80 KMT2A (0.46) MDM2KMT2ACASP3PTPN1FFAR1
SCHEMBL29719396 0.79 KMT2A (0.53) MDM2KMT2ACASP3FFAR4
SCHEMBL8769212 0.79 KMT2A (0.53) MDM2KMT2ACASP3FFAR4
SCHEMBL3367289 0.79 KMT2A (0.45) MDM2KMT2ACASP3PTPN1FABP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0677061-B1 POLYPEPTIDES AND ANTI-HIV AGENTS PREPARED THEREFROM SEIKAGAKU KOGYO CO LTD (JP) 1999-03-03 — — EP disclosed
US-5776899-A Polypeptide and anti-HIV agent prepared therefrom SEIKAGAKU CORPORATION (JP) 1998-07-07 — — US disclosed
US-5710128-A Pharmaceutical compositions of lipopolysaccharide-binding polypeptides YAMAMOTO, NAOKI (JP) 1998-01-20 — — US disclosed
US-5571892-A HAVING A C-TERMINUS; TREATMENT FOR AIDS SEIKAGAKU KOGYO CO., LTD. (JP) 1996-11-05 — — US disclosed
EP-0502198-B1 NOVEL POLYPEPTIDE AND ANTI-HIV DRUG PREPARED THEREFROM SEIKAGAKU KOGYO CO LTD (JP) 1995-12-27 — — EP disclosed
EP-0677061-A1 POLYPEPTIDE AND ANTI-HIV AGENT PREPARED THEREFROM SEIKAGAKU CORPORATION (JP) 1995-10-18 — — EP disclosed
US-5449752-A Viricides against human immunodeficiency virus; microbiocides SEIKAGAKU KOGYO K.K. (JP) 1995-09-12 — — US disclosed
WO-1995010534-A1 POLYPEPTIDE AND ANTI-HIV AGENT PREPARED THEREFROM SEIKAGAKU CORPORATION (JP) 1995-04-20 — — WO disclosed
EP-0513613-B1 Novel polypeptides with affinity to lipopolysaccharides and their uses SEIKAGAKU KOGYO CO LTD (JP) 1994-11-09 — — EP disclosed
EP-0331073-B1 BENZHYDRYLAMINE DERIVATIVES Chugai Seiyaku Kabushiki Kaisha (JP) 1993-07-28 — — EP disclosed
EP-0513613-A1 Novel polypeptides with affinity to lipopolysaccharides and their uses SEIKAGAKU KOGYO KABUSHIKI KAISHA (JP) 1992-11-19 — — EP disclosed
WO-1992019645-A1 A NOVEL POLYPEPTIDE WITH AFFINITY TO LIPOPOLYSACCHARIDES AND THEIR USES SEIKAGAKU KOGYO KABUSHIKI KAISHA (JP) 1992-11-12 — — WO disclosed
EP-0502198-A1 NOVEL POLYPEPTIDE AND ANTI-HIV DRUG PREPARED THEREFROM SEIKAGAKU KOGYO CO., LTD. (JP) 1992-09-09 — — EP disclosed
US-5051526-A Reagents for solid phase synthesis of polypeptides CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1991-09-24 — — US disclosed
US-4965405-A INTERMEDIATE FOR POLYPEPTIDE SYNTHESIS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1990-10-23 — — US disclosed
EP-0331073-A2 Benzhydrylamine derivatives Chugai Seiyaku Kabushiki Kaisha (JP) 1989-09-06 — — EP disclosed
Send feedback